Impact of a Bridge Device on the Loop Ileostomy

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Clinical Trial Summary

During the creation of an ileostomy, a bridge device is systematically placed in an aim to reduce wound and peritoneal contamination by stools. Nevertheless no evidence was reported to justify this issue. Moreover the placement of a bridge device increases the difficulty of nurse cares and is associated with its own morbidity.

See also
	Status	Clinical Trial	Phase
	Completed	`NCT02618720` - Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery	Phase 3
	Terminated	`NCT03437746` - Impact of Preoperative Single Corticosteroid Flash on Morbidity After Colorectal Resection: Monocentric Prospective Pilot Study	Phase 2

NCT number	NCT02756273
Study type	Interventional
Source	Centre Hospitalier Universitaire, Amiens
Contact
Status	Active, not recruiting
Phase	N/A
Start date	May 10, 2016
Completion date	October 2, 2023

Impact of a Bridge Device on the Loop Ileostomy — IBIP

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms